Owens & Minor (OMI) was Downgraded by Robert W. Baird to ” Underperform” while Lowering the Price Target of the company shares to $ 32 from a previous price target of $36 . Earlier the firm had a rating of “Neutral ” on the company shares. Robert W. Baird advised their investors in a research report released on Apr 21, 2016.
Many Wall Street Analysts have commented on Owens & Minor. Owens & Minor was Initiated by Credit Suisse to “Underperform” on Mar 16, 2016.
On the company’s financial health, Owens & Minor reported $0.54 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Oct 27, 2015. Analyst had a consensus of $0.47. The company had revenue of $2471.70 million for the quarter, compared to analysts expectations of $2487.48 million. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.42 EPS.
Owens & Minor opened for trading at $40.8 and hit $41.3001 on the upside on Monday, eventually ending the session at $41.19, with a gain of 0.73% or 0.3 points. The heightened volatility saw the trading volume jump to 4,10,084 shares. Company has a market cap of $2,582 M.
In a different news, on Feb 24, 2016, Richard W Mears (SVP, Chief Information Officer) sold 6,000 shares at $39.11 per share price. According to the SEC, on Feb 23, 2016, James E Rogers (director) sold 1,800 shares at $39.83 per share price. On Feb 18, 2016, Erika T Davis (SVP, Chief of Staff) sold 5,301 shares at $38.70 per share price, according to the Form-4 filing with the securities and exchange commission.
Owens & Minor Inc. is a healthcare logistics company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products supplies and devices. The Company operates in two segments: Domestic and International. Domestic segment includes all functions in the United States relating to its role as a healthcare logistics company providing distribution packaging and logistics services to healthcare providers and manufacturers. International segment consists of its European third-party logistics and packaging businesses. It is focused on its operations on healthcare logistics services and provides its customers with a service portfolio that covers procurement inventory management delivery and sourcing of products for the healthcare market. Its customers include hospitals integrated healthcare systems group purchasing organizations manufacturers of life-science and medical devices and supplies including pharmaceuticals.